Physician Profile
Based in Naperville, IL, Michael L. Sams, M.D., P.T. is listed in the NPI registry under rheumatology. Michael is also listed as specializing in internal medicine and physical therapist. According to Medicare claims data, Michael cared for 2,502 Medicare patients across 56,862 services. The services billed most often include injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered), injection, denosumab, 1 mg, and insertion of needle into vein for collection of blood sample.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.
Source: NPPES NPI Registry
1020 E OGDEN AVE STE 304
Naperville, IL 60563
Within Rheumatology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Autoimmune
Bone
Bone Health
Connective Tissue
Genetic & Connective Tissue
Inflammatory
Joints
Nerve & Tendon
Skin & Soft Tissue
Skin & Vascular
Soft Tissue
Spine & Back
Vascular
Most searched procedures
Consultation
Consultations
Diagnostics & Injections
Education & Support
Imaging
Injections
Lab & Diagnostics
Lab Work
Medication Management
Pain Relief
Regenerative Medicine
56,862 services · 2,502 patients · 25 distinct codes
| Procedure | Type | Code | Services |
|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
647 |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
141 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96401 |
41 |
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Drug given | J0717 |
50,475 |
| Injection, denosumab, 1 mg | Drug given | J0897 |
1,500 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Drug given | J3301 |
70 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | Office visit | 99214 |
570 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Lab test | 85025 |
507 |
| Red blood cell sedimentation rate, to detect inflammation, automated | Lab test | 85652 |
506 |
| Measurement c-reactive protein for detection of infection or inflammation | Lab test | 86140 |
505 |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Michael L. Sams, M.D. is a rheumatologist in Naperville, IL. That is the designation recorded for this NPI in the federal registry, where it is listed as “Rheumatology”.
NPI registry
Michael L. Sams, M.D. is listed at 1020 E Ogden Ave Ste 304, Naperville, IL 60563. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (630) 268-0200. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
Michael L. Sams, M.D.'s National Provider Identifier is 1346232048. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Michael L. Sams, M.D. attended Other, graduating in 2008. This comes from the CMS National Downloadable File.
CMS public data
Michael L. Sams, M.D. has 18 years experience. Calculated from a graduation year of 2008, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Michael L. Sams, M.D. performs procedures including insertion of needle into vein for collection of blood sample; provides treatments such as injection of drug or substance under skin or into muscle and administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Michael L. Sams, M.D.. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.